Streetbeat News

AKAN

Akanda Corp.

https://www.akandacorp.com

Industry

Drug Manufacturers - Specialty & Generic

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Open

1.41

Mkt cap

2M

Volume

60K

High

1.44

P/E Ratio

N/A

52-wk high

56.80

Low

1.32

Div yield

N/A

52-wk low

1.22

In Thursday's after-market session, several health care stocks experienced significant price movements. Notable gainers included NewGenIvf Group (NIVF) with a 58.1% increase, and SunLink Health Systems (SSY) with a 17.13% rise. On the losing side, Klotho Neurosciences (KLTO) fell by 6.5%, and Humana (HUM) declined by 4.76%.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 8:31 pm

In Wednesday's after-market session, several healthcare stocks experienced significant price movements. Notable gainers included Tevogen Bio Holdings, MSP Recovery, and TC BioPharm, while 10x Genomics and Trinity Biotech were among the losers.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 8:31 pm

Lawmakers are pressing the DEA to finalize a proposal to reschedule marijuana, which could impact the cannabis industry and related stocks.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 3:44 pm

The DEA is proposing significant increases in production quotas for marijuana compounds and psychedelics like psilocybin and ibogaine to support research and clinical trials. This move reflects growing interest in these substances for medical and scientific purposes.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 5:41 pm

Akanda Corp. has obtained a hemp cultivation license in Canada, enhancing its strategic position in the cannabis market. This development is part of its agreement with 1107385 B.C. LTD, reinforcing Akanda's commitment to its global cannabis industry leadership.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 4:44 pm

Roger Stone, a longtime ally of former President Donald Trump, believes that Trump's endorsement of a Florida marijuana legalization initiative would guarantee its victory. Trump has yet to take a definitive stance but has indicated he will make a statement soon. The initiative, Amendment 3, has mixed support and opposition, with significant financial backing on both sides. The measure would allow adults 21 and older to purchase and possess cannabis, potentially generating significant tax revenue for the state.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 3:43 pm

DoorDash shares surged 10% in pre-market trading after reporting better-than-expected Q2 revenue. Other notable pre-market movers include VSee Health (+123.4%), Akanda Corp (+34.5%), and Intel (-21.9%).

Portfolio Pulse from Avi Kapoor

August 02, 2024 | 12:15 pm

President Biden announced on X that he is ensuring no one goes to jail for mere use or possession of marijuana and that their records should be expunged. This move aims to address historic wrongs related to marijuana convictions.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 2:22 pm

The article highlights the pre-market movements of 12 health care stocks on Tuesday. Notable gainers include Viracta Therapeutics (VIRX), Purple Biotech (PPBT), Akanda (AKAN), Viridian Therapeutics (VRDN), IGC Pharma (IGC), and OpGen (OPGN). Significant losers include ProKidney (PROK), Nuwellis (NUWE), Virax Biolabs Group (VRAX), SILO Pharma (SILO), iSpecimen (ISPC), and FibroBiologics (FBLG).

Portfolio Pulse from Benzinga Insights

June 11, 2024 | 12:06 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.